Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06153940

Everglade Stem, World Cup and World Liner Post Market Clinical Follow-up

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Signature Orthopaedics · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of the Study is to monitor the performance of the Signature Orthopaedics Everglade Stem, World Acetabular Cup and World Liner as a part of post-market vigilance and continuous improvement efforts.

Detailed description

The Objective of this Post market Clinical Follow up (PMCF) study is to collect data confirming safety, performance and clinical benefits of the Everglade Stem, World Acetabular Cup and World Liner when used for a primary total hip arthroplasty at 2 years follow-up. This prospective follow-up series is necessary to gather data for the Everglade Stem, World Acetabular Cup and World Liner as they are recently launched to the market. The data concerning the performance and safety of the devices are gathered in various time frames starting with pre-operative status and then includes operative, at discharge, i year post-operative and 2 year post-operative evaluations. The revision rate of the components will be monitored as the primary objective, along with pre- and post-operative measurement of the Oxford Hip Score(OHS) patient-reported outcome measure(PROM) to quantify patient satisfaction and radiographic analysis to monitor the bony response to the implants and quantify the effectiveness of the cementless fixation.

Conditions

Interventions

TypeNameDescription
DEVICETreatmentThe Everglade™ Stem, is a second generation cementless blade style hip stem Forged in Titanium and proximally Antero-Posterior (AP) flared with Titanium Plasma Spray + Hydroxyapatite (TPS + HA) coated for bone on-growth. The stem has distal geometry and a polished anodized surface finish to minimize the stem hanging in Dorr A femurs. The World Acetabular Cup is a porous coated and mated with the Cross-linked polyethylene World Liner

Timeline

Start date
2023-11-22
Primary completion
2028-03-01
Completion
2028-03-01
First posted
2023-12-01
Last updated
2023-12-01

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06153940. Inclusion in this directory is not an endorsement.